Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance

空气污染引起的炎症、肥胖和胰岛素抵抗的表观基因组学

基本信息

  • 批准号:
    9098288
  • 负责人:
  • 金额:
    $ 55.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-06-01 至 2020-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Obesity and type II diabetes (T2D) have been increasing globally at epidemic proportions. Epidemiological studies indicate that air pollution is an environmental risk factor for development of insulin resistance (IR) and T2D. However, the mechanisms by which air pollution exposure causes progressive IR leading to T2D remain unclear. There is increasing evidence that IR, which often precedes the T2D by decades, may be modulated through epigenetic changes. Gestation and early childhood are periods of enhanced vulnerability to air pollution and also coincide with the stage at which epigenetic patterning is first established. We have previously established in mouse models that concentrated ambient pollution (CAP) exposure for >12 weeks potentiates the development of obesity, IR and T2D, and also induces a range of abnormalities that are prototypical for IR and T2D, including changes in immune function in systemic tissues (hypothalamus, circulation and adipose), reduced brown adipose tissue function, hepatic endoplasmic reticulum stress/steatosis and prototypical defects in insulin signaling in insulin response tissues such as liver, skeletal muscle and adipose. We have further demonstrated that early age is a period of vulnerability, as exposure to CAP during this period accelerates development of IR with overt changes in glycemic control developing in <10 weeks. Further, these defects are secondary to critical alterations in reactive oxygen species (ROS) pathways and inflammation in insulin responsive tissues. CAP exposure also results in genome-wide increases in in 5-mC. Hypothesis: Air pollution exposure results in global epigenetic alterations that result in metaboli re-programming in target tissues leading to obesity and insulin resistance. We posit that epigenetic programming during vulnerable periods of development (e.g. in utero or early childhood) is particularly prone to irreversible changes in the epigenome and the persistence of IR. This project will leverage access to state-of- the-art ambient exposure facilities, investigatie expertise in exposure science, disease pathways and epigenetics available at the University of Maryland and Johns Hopkins University to accomplish these specific aims. SA1: To characterize the epigenomic changes in response to air pollution that may either precede or overlap with the development of an insulin resistant phenotype. SA2: To define the IR and global epigenomic changes associated with early life CAP exposures. SA3: To determine whether cessation of air pollution exposure reverses insulin resistance and corresponding epigenomic changes. SA4: To integrate the epigenomic and transcriptomic perturbations that track with the development of the IR phenotype. These animal model studies with our well optimized controlled air pollution exposure that cause metabolic syndrome will reveal comprehensive epigenomic marks that precede the phenotype and are conserved between the target and surrogate tissues. The data will provide new leads for validation of mechanisms as well insight into interpretation of human studies.
 描述(由申请人提供):肥胖和 II 型糖尿病 (T2D) 在全球范围内呈流行趋势,流行病学研究表明,空气污染正在加剧。 胰岛素抵抗 (IR) 和 T2D 的环境风险因素 然而,空气污染导致 IR 导致 T2D 的机制仍不清楚。越来越多的证据表明,IR 可能比 T2D 早发生数十年。妊娠期和幼儿期是对空气污染的脆弱性增强的时期,也与表观遗传模式首次建立的阶段一致,我们之前在小鼠模型中建立了集中环境污染(CAP)暴露超过 12 周的阶段。加剧肥胖、IR和T2D的发展,并诱导一系列IR和T2D的典型异常,包括全身组织(下丘脑、循环和脂肪)免疫功能的变化、棕色脂肪组织功能降低、肝内质网我们进一步证明,早年是一个时期。脆弱性,因为在此期间暴露于 CAP 会加速 IR 的发展,并在不到 10 周内血糖控制发生明显变化。此外,这些缺陷是活性氧 (ROS) 途径和胰岛素反应组织炎症的关键改变的继发因素。 CAP 暴露还会导致全基因组 5-mC 增加。假设:空气污染暴露会导致整体表观遗传改变,从而导致目标组织的代谢重新编程,从而导致肥胖和胰岛素抵抗。发育时期(例如在子宫内或幼儿期)特别容易发生表观基因组不可逆转的变化和 IR 的持续性。该项目将利用最先进的环境暴露设施、暴露科学、疾病方面的研究专业知识。马里兰大学和约翰霍普金斯大学可利用的途径和表观遗传学来实现这些特定目标 SA1:表征可能先于或与胰岛素抵抗表型的发展重叠的表观基因组变化。定义与生命早期 CAP 暴露相关的 IR 和整体表观基因组变化 SA3:确定停止空气污染暴露是否会逆转胰岛素抵抗和相应的表观基因组变化 SA4:整合与 IR 发展相关的表观基因组和转录组扰动。这些动物模型研究采用我们精心优化的受控空气污染暴露引起的代谢综合征,将揭示先于表型并在目标组织和替代组织之间保守的全面表观基因组标记,这些数据将为研究提供新的线索。机制验证以及对人类研究解释的洞察。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shyam Biswal其他文献

Shyam Biswal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shyam Biswal', 18)}}的其他基金

Neurotoxicity due to Environmental complex Metal Mixtures Exposure
环境复杂金属混合物暴露引起的神经毒性
  • 批准号:
    10591120
  • 财政年份:
    2022
  • 资助金额:
    $ 55.66万
  • 项目类别:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
LKB1 和 KEAP1 突变的串扰驱动肺腺癌的生长
  • 批准号:
    9262182
  • 财政年份:
    2016
  • 资助金额:
    $ 55.66万
  • 项目类别:
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
空气污染引起的炎症、肥胖和胰岛素抵抗的表观基因组学
  • 批准号:
    9275991
  • 财政年份:
    2016
  • 资助金额:
    $ 55.66万
  • 项目类别:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
LKB1 和 KEAP1 突变的串扰驱动肺腺癌的生长
  • 批准号:
    9897626
  • 财政年份:
    2016
  • 资助金额:
    $ 55.66万
  • 项目类别:
Harmful Constituents and Respiratory Effects of Waterpipe Smoke
水烟烟雾的有害成分和对呼吸系统的影响
  • 批准号:
    9185357
  • 财政年份:
    2016
  • 资助金额:
    $ 55.66万
  • 项目类别:
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
LKB1 和 KEAP1 突变的串扰驱动肺腺癌的生长
  • 批准号:
    9107950
  • 财政年份:
    2016
  • 资助金额:
    $ 55.66万
  • 项目类别:
Mechanistic evaluation of broccoli sprout extract in preclinical COPD models
西兰花芽提取物在临床前慢性阻塞性肺病模型中的作用机制评估
  • 批准号:
    8628259
  • 财政年份:
    2014
  • 资助金额:
    $ 55.66万
  • 项目类别:
Pulmonary effects of biomass fuel indoor PM from rural India
印度农村生物质燃料室内 PM 对肺部的影响
  • 批准号:
    8210689
  • 财政年份:
    2012
  • 资助金额:
    $ 55.66万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 55.66万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 55.66万
  • 项目类别:

相似国自然基金

基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanisms of adipocyte loss in mouse models of familial partial lipodystrophy 2
家族性部分脂肪营养不良小鼠模型脂肪细胞丢失的机制2
  • 批准号:
    10748790
  • 财政年份:
    2023
  • 资助金额:
    $ 55.66万
  • 项目类别:
Identification of lung resident innate lymphocytes that specifically protect neonates from SARS-CoV-2 infections
鉴定可特异性保护新生儿免受 SARS-CoV-2 感染的肺固有淋巴细胞
  • 批准号:
    10742495
  • 财政年份:
    2023
  • 资助金额:
    $ 55.66万
  • 项目类别:
The Influence of Developmental Exposure to Maternal Overnutrition and Metformin on Offspring Mitochondrial Health and Beta Cell Function
发育期暴露于母亲营养过剩和二甲双胍对后代线粒体健康和 β 细胞功能的影响
  • 批准号:
    10601500
  • 财政年份:
    2023
  • 资助金额:
    $ 55.66万
  • 项目类别:
Prolactin receptor signaling regulates adaptation of the heart during pregnancy and postpartum
催乳素受体信号传导调节怀孕和产后心脏的适应
  • 批准号:
    10662892
  • 财政年份:
    2023
  • 资助金额:
    $ 55.66万
  • 项目类别:
Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center
青年发病 2 型糖尿病的预测因子:UAB 临床中心
  • 批准号:
    10582927
  • 财政年份:
    2023
  • 资助金额:
    $ 55.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了